Senior Care News

BURBANK, CA–(Marketwire – August 11, 2010) –  Imaging3™, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that on Thursday August 12, 2010 at 1:00pm PST, (4:00pm EST) the company’s CEO, Mr. Dean Janes, will be hosting a conference call. To join the conference call, please call 1-888-373-5705 and enter passcode 364039 followed by the pound sign (#). You will be connected to the conference call in a listen only mode, and then lines will be opened for questions following the presentation.

The purpose of the call is to update Shareholders and other interested parties of the current developments with the company.

A limited number of lines will be available for this conference call. The lines will open up 5 minutes prior to the start of the call.

A recording of the conference call will be made available on the company’s website as soon as it is available. Imaging3 will notify shareholders and others who subscribe to the company newsletter. Anyone who would like to be added to this list is encouraged to sign-up for the e-mail based newsletter on the company’s website using the following link — http://www.imaging3.com/newsletters_signup.html.

About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company’s website at http://www.imaging3.com for more information.

Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction and potential product liability claims, and other factors detailed in reports filed by the Company.

WEST PALM BEACH, FL–(Marketwire – August 10, 2010) – HearUSA, Inc. (NYSE Amex: EAR), a
leader among the nation’s hearing care providers, reported financial
results for the second quarter ended June 26, 2010.

Financial Results for Second Quarter 2010

In the second quarter of 2010, net revenues increased 9% to $21.4 million
from $19.6 million in the previous quarter, but decreased 6% from $22.7
million in the second quarter of 2009. The decrease year-over-year was
principally the result of some insurance plans eliminating, changing or
limiting their hearing care benefits at the beginning of 2010. The company
implemented a number of plans and strategies during the first quarter of
2010 which helped to replace most of the lost insurance business, including
increased marketing to its existing insurance base and private pay
customers. The company also increased the marketing of its AARP Hearing
Care Program and made it available to AARP members in 45 states through all
177 HearUSA centers and a network of independent AARP Hearing Care Program
providers. These combined efforts were the primary cause of the 9% increase
in second quarter revenue over the previous quarter.

The loss from continuing operations totaled $1.9 million in the second
quarter of 2010, compared to a loss of $2.5 million in the previous
quarter, and income of $963,000 in the second quarter of 2009. The loss
from continuing operations includes AARP advertising costs of $957,000
incurred in the second quarter of 2010 compared to $253,000 in the previous
quarter and none incurred in the second quarter of 2009. Advertising,
royalties and administrative costs associated with the AARP program totaled
$1.3 million in the second quarter of 2010, $588,000 in the previous
quarter and $142,000 in the second quarter of 2009.

Net loss attributable to common stockholders was $2.2 million or $(0.05)
per basic and diluted share in the second quarter of 2010, as compared to a
net loss of $2.7 million or $(0.06) per basic and diluted share in the
previous quarter of 2010, and net income of $1.1 million, or $0.03 per
basic and $0.02 per diluted share, in the same year-ago period. Net loss
attributable to common shareholders in the second quarter of 2009 included
income from discontinued operations of $336,000 or $0.01 per basic and
diluted share.

Management Commentary

“Our focus during the second quarter of 2010 was to increase revenues to
offset the loss of the managed care business in the first quarter and to
expand the reach of the AARP program,” said Stephen Hansbrough, CEO and
chairman of HearUSA. “The 9% increase in revenues over the first quarter of
2010 and the successful launch of the AARP program to AARP members in a
total of 45 states has given us a strong base for continued success going
into the third quarter.

“We have seen appointments grow at an accelerating pace since we launched
our AARP national advertising campaign, and AARP included the HearUSA
program in its publications and web sites in the latter half of the second
quarter. We expect this momentum to continue and believe that center
revenues will grow between 9% and 15% in the second half of 2010 when
compared to the first half, and our target is to grow center revenues 15%
to 20% in 2011 when compared to 2010.

“We will focus primarily on expanding the number of independent providers
participating in the AARP network during the rest of 2010 and expect to
have more than 800 participating providers by the end of the year,”
continued Mr. Hansbrough. “Both HearUSA and AARP will also continue to
increase awareness and member communications during the remainder of the
year. We believe that it will take time to fully develop the provider
network and educate the AARP membership base. Our targets for 2011 are to
expand the AARP network to more than 2,000 participating providers and
generate AARP network sales of over 30,000 units.”

Conference Call

HearUSA will hold a conference call at 4:30 p.m. Eastern time, August 10,
2010, to discuss its second quarter 2010 financial results. The company’s
senior management will host the presentation, which will be followed by a
question and answer period.

To participate in the call, dial the appropriate number 5-10 minutes prior
to the start time, request the HearUSA conference call and provide the
conference ID: 7HEARUSA.

Date: Tuesday, August 10, 2010
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Domestic callers: 1-800-862-9098
International callers: 1-785-424-1051
Conference ID#: 7HEARUSA

A Web simulcast and replay will be available via the investor relations
section of the company’s website at www.hearusa.com.

If you have any difficulty connecting with the conference call or webcast,
please contact the Liolios Group at 1-949-574-3860.

A telephone replay of the call will be available later that evening and
will be accessible until August 17, 2010:

Toll-free replay number: 1-877-870-5176
International replay number: 1-858-384-5517
Replay Pin Number: 11721

About HearUSA

HearUSA is the recognized leader in hearing care for the nation’s top
managed care organizations through its 177 company-owned centers and
network of more than 2,000 hearing care providers. HearUSA is the nation’s
only hearing care provider accredited by URAC, an independent, nonprofit
health care accrediting organization dedicated to promoting health care
quality through accreditation, certification and commendation. HearUSA is
also the administrator of the AARP Hearing Care Program, designed to help
millions of Americans aged 50+ who have untreated hearing loss. For more
information about HearUSA visit www.hearusa.com, or go to
www.hearingshop.com for a wide selection of hearing related products
available for purchase online.

Forward Looking Statements

This press release contains forward-looking statements within the meaning
of the Securities Litigation Reform Act of 1995, including those statements
that HearUSA plans to expand its AARP program to include more than 800
participating independent hearing care providers during the course of 2010
and over 2,000 participating providers in 2011; that the company expects
second quarter 2010 momentum to continue; that the company believes that
center revenues will grow between 9% and 15% in the second half of 2010
when compared to the first half of 2010; that the company’s target is to
grow revenues 15% to 20% in 2011 when compared to 2010; and that the
company plans to generate AARP network sales of over 30,000 units. These
statements involve certain risks and uncertainties that could cause actual
results to differ materially from those in the forward-looking statements.
Potential risks and uncertainties include such factors as the company’s
continuing ability to replace lost and decreased revenue from insurance
contracts with increased self-pay revenue, replacement insurance agreements
and other revenue; the company’s ability to attract and retain a sufficient
number of independent providers in all 50 states to participate in the AARP
program; the company’s ability to successfully integrate the AARP program
into its company-owned centers; the ability of the Company to capitalize on
the advertising efforts for the AARP program; the company’s ability to
control costs; the company’s ability to generate sufficient cash flows to
fund its various advertising campaigns; the ability of the company to
maintain unit sales of Siemens hearing aids; market demand for the
company’s goods and services; changes in the pricing environment; general
economic conditions in those geographic regions where the company’s centers
are located; consumer confidence in the general economy; the impact of
competitive products; and other risks and uncertainties described in the
company’s filings with the Securities and Exchange Commission, including
the company’s Form 10-K for the fiscal year ended December 26, 2009.

                               HearUSA, Inc.
                  Consolidated Statements of Operations
            Three Months Ended June 26, 2010 and June 27, 2009
                                (unaudited)


                                                 June 26,       June 27,
                                                   2010           2009
                                               ------------   ------------
                                                 (Dollars in thousands,
                                                except per share amounts)

Net revenues
Hearing aids and other products                $     19,796   $     20,653
Services                                              1,613          2,014
                                               ------------   ------------
Total net revenues                                   21,409         22,667
                                               ------------   ------------

Operating costs and expenses
Hearing aids and other products                       5,290          5,072
Services                                                412            388
                                               ------------   ------------
Total cost of products sold and services
 excluding depreciation and amortization              5,702          5,460

Center operating expenses                            12,209         10,908
General and administrative expenses                   3,769          3,661
Depreciation and amortization                           564            588
                                               ------------   ------------
Total operating costs and expenses                   22,244         20,617
                                               ------------   ------------
Income (loss) from operations                          (835)         2,050
Non-operating income (expenses)
Gain (loss) on foreign exchange                          (5)           375
Interest income                                           5              -
Interest expense                                       (841)        (1,252)
                                               ------------   ------------
Income (loss) from continuing operations
 before income tax expense                           (1,676)         1,173
Income tax expense                                     (220)          (210)
                                               ------------   ------------
Income (loss) from continuing operations             (1,896)           963
Discontinued operations attributable to
 HearUSA, Inc.
Income from discontinued operations, net of
 income tax benefit of $270 in 2009                       -            250
Gain on sale of discontinued operations                   -          1,632
Income tax expense on sale of discontinued
 operations                                               -         (1,546)
                                               ------------   ------------
Income from discontinued operations                       -            336
                                               ------------   ------------
Net income (loss)                                    (1,896)         1,299

Net income attributable to noncontrolling
 interest                                              (238)          (131)
                                               ------------   ------------
Net income (loss) attributable to HearUSA,
 Inc.                                                (2,134)         1,168
Dividends on preferred stock                            (32)           (35)
                                               ------------   ------------

Net Income (loss) attributable to HearUSA,
 Inc. common stockholders                      $     (2,166)  $      1,133
                                               ============   ============

Loss from continuing operations attributable
 to HearUSA, Inc. common stockholders per
 common share - basic                          $      (0.05)  $       0.02
                                               ============   ============
Loss from continuing operations attributable
 to HearUSA, Inc. common stockholders per
 common share - diluted                        $      (0.05)  $       0.02
                                               ============   ============

Net loss attributable to HearUSA, Inc. common
 stockholders per common share - basic         $      (0.05)  $       0.03
                                               ============   ============
Net loss attributable to HearUSA, Inc. common
 stockholders per common share - diluted       $      (0.05)  $       0.02
                                               ============   ============

Weighted average number of shares of common
 stock outstanding - basic                           44,922         44,837
                                               ============   ============

Weighted average number of shares of common
 stock outstanding - diluted                         44,922         45,340
                                               ============   ============

Amounts attributable to HearUSA, Inc. common
 stockholders:

Income (loss) from continuing operations, net
 of tax                                        $     (2,134)  $        832
Discontinued operations, net of tax                       -            336
                                               ============   ============

Net income (loss) attributable to HearUSA,
 Inc. common stockholders                      $     (2,134)  $      1,168
                                               ============   ============





                               HearUSA, Inc.
                        Consolidated Balance Sheets
                                (unaudited)


                                                 June 26,     December 26,
ASSETS                                             2010           2009
                                               ------------   ------------
                                                 (Dollars in thousands,
                                                except per share amounts)
Current assets
Cash and cash equivalents                      $      4,026   $      7,037
Short-term marketable securities                      1,306          4,106
Accounts and notes receivable, less allowance
 for doubtful accounts of $677 and $616               5,506          5,554
Inventories                                           1,409          1,844
Prepaid expenses and other                              417            464
                                               ------------   ------------
Total current assets                                 12,664         19,005
Property and equipment, net                           3,463          4,021
Goodwill                                             51,928         51,495
Intangible assets, net                               12,529         12,816
Deposits and other                                      698            731
Restricted cash and cash equivalents                  3,252          3,245
                                               ------------   ------------
Total Assets                                   $     84,534   $     91,313
                                               ============   ============

LIABILITIES AND STOCKHOLDERS'  EQUITY
Current liabilities
Accounts payable                               $      9,458   $      7,070
Accrued expenses                                      1,907          2,253
Accrued salaries and other compensation               3,224          3,520
Current maturities of long-term debt                  5,357          5,983
Income taxes payable                                      -          1,974
Dividends payable                                        35             35
                                               ------------   ------------
Total current liabilities                            19,981         20,835
                                               ------------   ------------
Long-term debt                                       33,781         36,139
Deferred income taxes                                 7,775          7,335
                                               ------------   ------------
Total long-term liabilities                          41,556         43,474
                                               ------------   ------------
Commitments and contingencies
                                               ------------   ------------

Stockholders' equity
Preferred stock (aggregate liquidation
 preference $2,330, $1 par, 7,500,000 shares
 authorized)
Series H Junior Participating
 (none outstanding)                                       -              -
Series J (233 shares outstanding)                         -              -
                                               ------------   ------------
Total preferred stock                                     -              -

Common stock: $.10 par; 75,000,000 shares
 authorized 45,451,160 and 45,381,750 shares
 issued                                               4,545          4,538
Additional paid-in capital                          138,359        137,863
Accumulated deficit                                (119,804)      (114,982)
Treasury stock, at cost: 523,662 common shares       (2,485)        (2,485)
                                               ------------   ------------
Total HearUSA, Inc. Stockholders' Equity             20,615         24,934

Noncontrolling interest                               2,382          2,070
                                               ------------   ------------
Total Stockholders' equity                           22,997         27,004
                                               ------------   ------------
Total Liabilities and Stockholders' Equity     $     84,534   $     91,313
                                               ============   ============

SUNRISE, FL–(Marketwire – August 4, 2010) –  Interim HealthCare® Inc., the nation’s first and finest healthcare and in-home senior care franchise company, is offering Philadelphia residents the opportunity to own their own business with an Interim HealthCare franchise. With a network of more than 300 independently owned franchises across the country, Interim is now seeking franchisee candidates in Philadelphia to be part of an aggressive growth campaign designed to increase its U.S. presence over time. 

Interim’s senior care franchises include non-medical and medical personal care, nursing and healthcare staffing services. The system has a 40 year history within the healthcare industry and many of their franchisees have an average tenure of 24 years.

Executives from Interim will be in town to host a franchise opportunities seminar on August 17 at 7:00 p.m. at the Crowne Plaza – Valley Forge located on 260 Mall Boulevard for all interested candidates. To register for the event and learn more, please log onto www.interimfranchising.com or call 866-767-4730.

“Interim HealthCare has been assisting patients and their families since 1966 and we are excited to expand our footprint in Philadelphia,” said Kathleen Gilmartin, CEO of Interim Healthcare. “We’re looking for interested individuals to join our team who have the sensitivity and compassion needed in our business to help our customers when it matters most.”

Currently with more than15 locations in Pennsylvania, Interim is looking to expand its presence throughout the state by indentifying eight new openings in Philadelphia over four years. Qualified candidates should possess a minimum net worth of $400,000, and a minimum liquidity of $50,000. Franchisees can expect their initial investment to range from approximately $115,500 to $188,500 including the franchise fee.

“Today there are 1 in 8 people 65 or older and by 2030 there will be more than twice that number,” said Gilmartin. “Therefore the growing senior population and home care growth market is a great niche for franchising and with additional Interim HealthCare franchises in the Philadelphia area, we will help the increasing need,” said Gilmartin.

Franchisees utilize comprehensive operations, financial, training, and sales systems to assist in operating their business at maximum efficiency and effectiveness. Additionally, they receive extensive local and national marketing support throughout the year. Interim HealthCare franchise owners share a commitment to improving the lives of their patients and communities, and they continue to realize opportunities for growth in the growing baby boomer segment and home care industry.

About Interim HealthCare:
Founded in 1966, Interim HealthCare® is the nation’s oldest proprietary national health care franchise organization providing health care personnel at all skill levels in all settings. Through a comprehensive network of more than 300 independently owned franchise offices, Interim HealthCare® franchisees are the largest combined provider of community-based home care (skilled and non-medical) and health care staffing. Interim HealthCare is unique in combining the commitment of local ownership with the support of a national organization that develops innovative programs and quality standards that improve the delivery of service through franchisees who employ more than 75,000 health care workers who serve 50,000 people each day. For more information or to locate an Interim HealthCare office, visit www.interimhealthcare.com.

Click here to see all recent news from this company

SPRINGFIELD, OH–(Marketwire – August 4, 2010) –  AdCare Health Systems, Inc. (NYSE Amex: ADK), an Ohio-based long-term care, home care and management company, has closed the sale of an additional 225,400 shares of common stock at the offering price of $3.50 per share for gross proceeds of $788,900, pursuant to the over-allotment option exercised by the underwriter in connection with AdCare’s offering that closed on June 30, 2010.

The full exercise of the over-allotment option brings the total number of common shares sold by AdCare in the offering to 1,939,686 and gross proceeds to approximately $6.8 million. The aggregate net proceeds to the company from the offering totaled approximately $6.1 million, after deducting underwriting discounts, commissions, legal fees and other offering-related expenses payable by the Company. AdCare plans to use the net proceeds of the offering for acquisition purposes, working capital and general corporate purposes. As of the close of the exercise of the over-allotment, the Company has approximately 7.5 million common shares outstanding.

C. K. Cooper & Company was the sole manager for the public offering.

This press release does not constitute an offer to sell or solicitation of an offer to buy any securities. Any such offer may be made only pursuant to the company’s prospectus supplement and accompanying base prospectus for the offering and only in states in which the offering is registered or exempt from registration and by broker-dealers authorized to do so. The securities offered by the prospectus involve a high degree of risk. Copies of the prospectus supplement and accompanying base prospectus may be obtained from the SEC’s website at www.sec.gov or from C. K. Cooper & Company, 18300 Von Karman Avenue, Suite 700, Irvine, California 92612, Attention: Hue Lapham/Syndicate Department, or [email protected], or via fax +1-949-477-9211.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) develops, owns and manages assisted living facilities, nursing homes and retirement communities and provides home healthcare services. Prior to becoming a publicly traded company in November of 2006, AdCare operated as a private company for 18 years. AdCare’s 900 employees provide high-quality care, management services and other services for patients and residents residing in 19 facilities, seven of which are assisted living facilities, 11 skilled nursing centers and one independent senior living community. The company owns eight of those facilities. In the ever-expanding marketplace of long-term care, AdCare’s mission is to provide quality healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Click here to see all recent news from this company

MENOMONEE FALLS, WI–(Marketwire – July 23, 2010) –  Assisted Living Concepts, Inc. (NYSE: ALC) announced that it plans to release its 2010 second quarter financial results after the New York Stock Exchange closes on Monday August 9, 2010. The release will be posted on ALC’s website at www.alcco.com. ALC has scheduled a conference call on Tuesday August 10, 2010 at 10:00 a.m. (ET) to discuss its financial results for the second quarter. The toll-free number for the live call is (800) 230-1096 or international (612) 332-0107. A taped rebroadcast of the conference call will be available approximately three hours following the live call until midnight on September 10, 2010, by dialing toll free (800) 475-6701 or international (320) 365-3844 and using access code 165684.

About Us

Assisted Living Concepts, Inc. and its subsidiaries operate 211 senior living residences with capacity for approximately 9,400 residents in 20 states in the United States. ALC’s residences typically consist of 35 to 60 units and offer residents a supportive, home-like setting and assistance with activities of daily living. ALC employs approximately 4,100 people.

LANHAM, MD–(Marketwire – July 23, 2010) –  The Residence at Greenbelt, offering the new standard in modern assisted living, announced today that it will celebrate its grand opening on Tuesday, July 27^th and Wednesday, July 28^th, 2010 from 4pm-7pm. During this monumental two-day event, guests can experience a VIP tour of The Residence on Greenbelt, its new modern models and see first-hand the dignity and vitality of assisted living in a unique community geared towards residents, their families and friends. 

A special tree-planting dedication ceremony will take place on the second day, Wednesday, July 28^th. Samuel H. Dean, Councilman for Ward 6 in Prince George’s County, will lead the dedication of a Southern Magnolia tree that was graciously donated by Behnke Nurseries. Additionally, summer fare and jazz entertainment will be provided both days.

At The Residence on Greenbelt, the warmth and comfort of home and modern convenience come together to define modern assisted living. This unique community offers charm, extensive care and superior care, while allowing residents to experience its modern set of amenities including a Skype lounge and stately movie theatre equipped for the hearing impaired. Conveniently located on Greenbelt Road, The Residence on Greenbelt has recently undergone a complete renovation that has created a vibrant and interesting senior living residence, where residents can experience unrivaled service in modern and fun surroundings.

Three different service programs exist at The Residence on Greenbelt, providing the right match for the needs of seniors. In addition to Assisted Living, the community offers a Special Needs living area that provides for residents with higher acuity and mobility needs in an environment with features focused on maximizing independence while offering comfort and service. The Residence on Greenbelt also provides the Pathways Memory Care Program, an exceptional option for seniors with memory impairments as it offers a stimulating and engaging environment for residents and peace of mind for their families and friends.

For more information about The Residence on Greenbelt, or to attend the Grand Opening event, please call (866) 712-1172 or visit TheResidenceonGreenbelt.com.

About IntegraCare
IntegraCare’s mission is to “improve the quality of life for its employees, residents, and their families.” The company’s goal is to create an environment where its primary customer, the employee, experiences respect, dignity, and personal development. By providing this environment for its employees, the second half of our mission, “improve the quality life for our residents and their families,” will be achieved.

CORAL SPRINGS, FL–(Marketwire – July 22, 2010) –  Willing Holding, Inc. (OTCBB: WHDX) announces that it has completed the acquisition of Accessible Home Health Care.

On July 16, 2010, Willing Holding, Inc. completed the acquisition of the assets of Accessible Home Health Care (www.accessiblehhc.com) from Valiant Healthcare, Inc., a Delaware corporation, through the execution and closing of an Asset Purchase Agreement. Under the reverse merger Valiant (www.valianthealthcare.com) has assumed majority (90%) interest in Willing Holding.

Accessible’s and Valiant’s entire experienced management team has been retained and they continue to run the day to day business of the company.

Accessible’s business model is designed to lead and direct the 21st Century demands of the long term home health care industry by offering a “Complete Home Healthcare Package™” and being a “One Stop Provider™.” Accessible’s primary mission is to provide the highest quality home health care services and products to its patients while adding value to the payers by reducing direct costs and the potential for fraud.

Accessible’s next phase of growth is to expand its company owned units by acquisition of Medicare certified home health care providers in strategic geographic markets.

About Willing Holding, Inc.
Through our Accessible Home Health Care division, we offer and sell a proven one of its kind franchise opportunity to establish and operate a full service medical and personal care Accessible Home Health Care franchise, under our distinctive brand and system. As of July 22, 2010 there are 96 Accessible Home Health Care franchise units and one company-owned unit in 24 states, as well as in India and Kenya.

Forward-Looking Statements
This release is not an offer to purchase or sell securities and may contain statements that are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current estimates and projections about Willing Holding, Inc.’s business, which are derived in part on assumptions of its management, and are not guarantees of future performance, as such performance is difficult to predict. The Company assumes no obligation to update information concerning its expectations.

FRIENDSWOOD, TX–(Marketwire – July 20, 2010) – TrinityCare Senior Living, Inc. (OTCBB: TCSR), today announced they have been awarded a patent for the Company’s interactive family communication system, Seniors In Touch (SIT).

“Seniors In Touch allows senior adults to use a simple touch screen computer system to send and recieve video messages, email, pictures, and other digital media,” says Brian Lang, Chief Executive Officer of SIT. “Family and friends from across town or across the nation can share messages, memories, and daily activity using the Internet, hand held technology, and other creative media. The award of this patent recognizes SIT’s technical and social media innovation.” The Company previously announced the implementation of this technology together with CoVideo Systems, a leader in providing video emailing, conferencing and presentation tools.

About Seniors In Touch

Seniors In Touch is an interactive communication system for senior adults and their families. Utilizing the latest in touch screen computing combined with established communication tools, seniors will be able to send text and video messages to persons in their contacts via a secure, user-friendly, touch interface. A family member serves as the administrator of the Seniors In Touch account to provide approved and safe interaction for the senior adult. Seniors In Touch will also provide photo-sharing services and limited web access for news, weather and sports that is approved by the administrator. The platform will also provide executive directors of senior living facilities a platform in which to communicate with both the senior adults and their families. For more information please visit www.seniorsintouch.com.

About TrinityCare Senior Living, Inc.

TrinityCare Senior Living (“TrinityCare”) develops, owns, and manages quality senior living facilities that focus on enriching the faith of the residents and providing state-of-the-art independent living, assisted living, memory care and adult day care services in a single location. The Company partners with local churches and developers for each facility and offers a wide range of both community and personal services to residents. TrinityCare is a rapidly growing company with three successful facilities currently operating in Texas and Tennessee. Near-term expansion plans target the Southeastern part of the United States. For more information please visit www.trinitycare.com.

TrinityCare is headquartered in Friendswood, Texas (Houston metropolitan area) and its common stock trades on the OTC Bulletin Board under the symbol “TCSR.”

Forward-Looking Statements

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements related to the future financial performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful execution of growth strategies, product development and acceptance, the impact of competitive services and pricing, general economic conditions, and other risks and uncertainties described in the Company’s periodic filings with the Securities and Exchange Commission.

SPRING, TX–(Marketwire – July 15, 2010) –  Dallas-based developer The LaSalle Group, Inc. is breaking ground on its third specialized Alzheimer’s and Memory Care Assisted Living Community in the Houston area, Autumn Leaves of Cypresswood, in Spring, TX. Company leadership, principal investors and other key partners will gather to see the newest addition to the Autumn Leaves family at official ground breaking ceremonies Tuesday, July 20 beginning at 11:00 a.m. Ceremonies will take place at the Cypresswood site located at 6327 Cypresswood Drive in Spring, TX. Local media and Spring area officials are invited to attend as well. 

Research of the Houston area has continued to show a demand for dedicated Alzheimer’s beds that exceeds the current supply. “We will continue to develop in the Houston market,” said Mitchell Warren, President of The LaSalle Group. “Our partners and investors recognize the pent-up need for our dedicated services that cater to this specific population and based on our in-depth market research results, we are committed to continuing our growth pattern in this market.” Autumn Leaves of Cypresswood will be the 15th property developed by LaSalle over the past ten years. Currently, The LaSalle Group has nine Autumn Leaves communities operating successfully in the Dallas/Fort Worth market and three in the greater Chicago area. The first Houston property to open, Autumn Leaves of The Woodlands, is set to accept their first residents in August; construction on the second Houston property, Autumn Leaves of Riverstone, is underway in Missouri City and scheduled to be completed in early Spring 2011. The company plans to continue their current expansion into the Houston market opening new communities in the area over the next three years.

Autumn Leaves of Cypresswood is scheduled to be completed and accepting residents by late Spring 2011. The property will feature 38 units and accommodate approximately 46 residents. For more information on this or other LaSalle Group projects, contact the home office at (214) 239-8400.

Construction and Management
Lake Superior Contracting, LaSalle’s in-house, full-service construction division, will coordinate and manage the design and construction of the new property ensuring the distinctive, research-based structural design attributed to all of LaSalle’s Autumn Leaves communities is in place. Sister firm Constant Care Management Company will manage and oversee all of the day-to-day operations once the community opens.

About The LaSalle Group, Inc. 
Family-owned and operated, The LaSalle Group (with its subsidiaries and affiliates) develops, builds, manages and owns specialized assisted living residences for people with Alzheimer’s and other forms of memory impairment, as well as other specialized real estate properties throughout the United States. For more information about our business, companies and current projects visit http://www.LaSalleGroup.com or call 1-800-452-7255. “Our Family Caring For Your Family”

About Alzheimer’s Disease
Alzheimer’s disease is a fatal and progressive brain disease that affects over 5.3 million Americans. Currently there is no cure and medications do not stop or reverse the disease. As the most common form of dementia, it accounts for more than approximately 60% of dementia cases.

Click here to see all recent news from this company

OXFORD, UK–(Marketwire – July 12, 2010) –  Mirada Medical Limited (“Mirada” or “the Company”)

Oxford, UK and Ohio, US, 12 July 2010: Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, announced today that Karsten Damgaard-Iversen has joined the Board of the Company as Non-Executive Chairman. 

Karsten Damgaard-Iversen is an internationally accomplished business professional with more than 30 years global experience of working within the healthcare imaging industry. He is a proven leader with a successful track record in operational and strategic management positions within small, medium and large medical imaging and healthcare technology companies. Mr. Damgaard-Iversen, aged 54, combines strong business acumen with in-depth technical and medical knowledge and has served in executive positions such as Managing Director and Chief Group Executive of Toshiba Medical Systems Europe BV, Managing Director of Toshiba Medical Systems (UK) Ltd., Vice President of International Operations of Fisher Imaging Corporation and Director of Sales & Marketing of Storz Medical AG. Mr. Damgaard-Iversen has also been a direct contributor to the invention and development of specific laser and x-ray based medical products. He holds an MBA from Emory University and a BSc in electronic engineering from Copenhagen University College.

In addition to his role as Chairman at Mirada Medical, Mr. Damgaard-Iversen is the founder and director of Disease Control Innovations Medical BV, a Dutch company engaged in product and EU business development of new medical technology that encompass innovative solutions to disease management and diagnosis. DCI Medical currently supports SonoCine Corporation, a privately held US inventor of automated whole breast ultrasound (AWBU) for screen detection of mammograhically occult breast cancer, and US quoted Imaging Diagnostic Systems, a pioneer in laser optical imaging systems.

Commenting on the appointment of the new Chairman, Hugh Bettesworth, CEO of Mirada Medical, said: “I am delighted that Karsten has chosen to join Mirada Medical as Chairman and that we have been able to attract such international talent from the medical imaging industry to our Board. Karsten’s experience in product development, together with his strategic and operational leadership, will provide Mirada with excellent guidance and steering as we continue to grow and prosper in the global oncology imaging marketplace.”

Commenting on his appointment as Chairman of the Board of Mirada Medical, Mr. Damgaard-Iversen said: “I am extremely impressed by Mirada’s innovative solutions for oncology disease management and cross modality decision support systems and I hope to be able to make a significant contribution to the growth and development of the Company. I look forward to working with the team at Mirada and applying my experience and know-how from the medical imaging arena to guide and support the future success of Mirada.” 

About Mirada Medical

Mirada Medical Limited develops internationally recognised medical imaging analysis applications that provide clinicians with an enhanced software package for the quantification of images, typically used in cancer diagnosis and treatment response assessment. Mirada Medical’s technology has broad applicability across nuclear medicine, diagnostic radiology, radiation oncology and medical oncology. Mirada Medical also markets products in neurology and cardiology. Mirada specialises in offering comprehensive and quantifiable analysis for the diagnosis, staging, treatment planning and assessment of treatment response in oncology. Mirada’s advanced technology allows medical images acquired using MRI, CT, SPECT or PET scanners to be combined into one, a process known as image fusion. Image fusion is useful in clinical interpretation as it allows different qualities of information to be combined into a single picture, for example, functional information such as metabolic activity, to be combined with anatomical information showing the precise location of pathology relative to bones and organs. This provides clinical users with a more complete picture, thereby improving the quality of information available when managing a patient’s condition. Mirada’s products are designed to support the comparison of multi-modal images acquired over any number of follow up visits by the patient, making them particularly well suited to the analysis of treatment response in longer term treatment plans such as those typical when treating cancer.

Mirada Medical was formed out of Oxford University by Professor Sir Michael Brady, one of the world’s leading medical imaging scientists. The Company is ISO 13485 certified and its technology has been supplied globally to customers in countries including the US, Japan, and Europe since 2001. Mirada’s products are sold by Mirada but also by major healthcare players such as McKesson, Siemens, Sectra, Carestream and Vital Images.

The Mirada team is a combination of world class scientists and exceptional engineers sourced from both Oxford University and leading blue-chip companies. For more information about Mirada Medical, please visit www.mirada-medical.com.

NEW YORK, NY–(Marketwire – July 6, 2010) –  In its ongoing effort to keep clients and key partners at the forefront of health promotion strategies in the workplace, Plus One hosted its annual Wellness Roundtable at the Cisco campus in San Jose, California today. Themed “Wellness Rx for the Future: Healthy Lifestyles as Medicine,” the event provided leaders from across the country the opportunity to explore how the most progressive companies and experts approach their employee wellness programs while achieving the greatest return on investment. 

Dr. Pam Hymel, Cisco’s Corporate Medical Director, led off the panel and discussed how Cisco executes on their vision for “enhancing the health and well-being of employees and their families leading to healthier, more fulfilling lives and greater productivity.” Through their comprehensive HealthConnections program, Cisco has created a vehicle to determine the most prevalent risk factors among their population, deliver targeted programs for engagement, and offer a single point of origin for family healthcare. 

Next, Dr. Kerry Olsen, Medical Director for Mayo Clinic’s Dan Abraham Healthy Living Center, reiterated the importance of the event’s theme that “exercise is medicine.” He shared how he and his team execute on their goal to “reach the hard to reach employees” and motivate them towards healthier lifestyles by focusing on the body, mind, and spirit. Through the Healthy Living Center’s utilization incentives, a direct correlation has been seen in risk factor reduction among Mayo’s population.

Ken Shachmut, Senior Vice President of Strategic Initiatives, Health Initiatives & Re-engineering for Safeway, closed the panel portion of the event. He shared how Safeway has been able to stand alone in holding their healthcare costs flat for the past five years through incentive based programs and more transparent employee communications. Comparing healthcare costs to Safeway’s core business, Ken asked attendees: “After you go grocery shopping, are you ever told you will receive a receipt after 30 days with the cost of purchase?”

Those attending the event took full advantage of the networking opportunities the setting provided, as well as toured the world class Cisco LifeConnections Health Center and Fitness Center managed by Plus One. Mike Motta, Plus One Co-Founder, President and Chief Executive Officer, hailed the success of the event: “The speakers today are testament to the power regular physical activity and comprehensive wellness programs can have on the health not only of a corporation’s employees, but their bottom line as well. I am proud that we were able to deliver an event like this for our clients and look forward to continuing to provide wellness solutions that deliver results.”

About Plus One
Plus One Health Management Inc. is a leading provider of comprehensive wellness solutions for corporations and other discerning organizations. From the design, development, and management of on-site wellness centers, to the creation and execution of results-focused employee wellness programs, to the five-star delivery of hospitality spa and fitness services, Plus One applies an integrated approach to individual and employee wellness. Clients include Fortune 500 companies, financial services firms, law partnerships, and world leaders in the media, biotechnology, energy, and pharmaceutical industries. Founded in 1986, today Plus One employs more than 1,500 professionals nationwide. For more information, please visit www.plusonehealthmanagement.com.

Click here to see all recent news from this company

FOOTHILL RANCH, CA–(Marketwire – July 6, 2010) –  Medical Marijuana Inc (PINKSHEETS: MJNA) reports significant progress on staffing of The Hemp Network. President Don Steinberg states, “In the past, Bruce Perlowin and I have created a global network of over 125,000 agents in 50 countries. We have the experience in all aspects of running a global MLM. Now we are in this new, exploding industry with a team of Doctors, immunologists, PhDs, and world renowned nutritionists to round out the products division. We have top network marketers signed up who have already created hundreds of web sites to support this new company. Alexa has rated ‘The Hemp Network’ website in the top 2%. This is after only 2 months which shows the power of this new opportunity. Our proprietary MLM software is nearing completion with a pay plan that is revolutionary. To participate in daily conference calls which discuss the pay plan, upcoming events and exchange of ideas, call 218-339-3600 PIN: 321677. Calls are held Monday through Thursday at 6:00 PM (PDT), which we invite the public to attend.”

Bruce Perlowin, CEO, stated, “The opportunity to be involved in the 1^st hemp network marketing company in history in which an existing culture of numerous movements already exist who are passionate about hemp is irresistible. Hemp enthusiast movements include the medical marijuana movement, the marijuana legalization movement, the hemp movement itself, the health, wellness and anti-aging movement, the environmental movement and the green movement. These existing cultural creative movements all herald the wonders of hemp in their various areas and are all natural and highly motivated individuals ripe to participate in The Hemp Network.”

SOLUTIONS

Medical Marijuana Inc has developed a suite of solutions to deliver an efficient and secure infrastructure for the Medical Marijuana Industry which provides the tools to industry operators to effectively manage their business with the confidence that they are in full compliance.

MEDICAL MARIJUANA INC’S TURNKEY COLLECTIVE SOLUTION

Medical Marijuana Inc’s Turnkey Collective Solution ensures that collectives operate within the guidelines of all laws and regulations regarding the tracking of the cannabis from grow cycle to final distribution. By employing Medical Marijuana Inc’s closed loop, patent pending, tracking system, it can be shown to authorities and collectives alike that the source of their supply was an active member of the collective.

TAX COLLECTION

MJNA’s Stored Value Platform System provides verifiable solutions to manage the difficult task of revenue and taxation collection. The customers of the dispensary are issued a plastic debit card or medical revenue card. The ease of access to certifiably secure transactions lessens the risk of loss at each level of the transaction.

ABOUT MEDICAL MARIJUANA INC

Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc to be materially different from the statements made herein.

CAMDEN, NJ–(Marketwire – July 1, 2010) –  Close on the heels of another major award from the National Institutes of Health (NIH), the Coriell Institute has announced its receipt of a five-year, $6-million NIH contract to manage the National Institute on Aging (NIA) Aging Cell Repository.

“Our long-standing expertise in the biobanking arena has been a decisive factor in maintaining major contracts such as the NIA Cell Repository,” said Coriell President and CEO, Michael F. Christman, Ph.D.

Coriell has overseen the Aging Cell Repository since its establishment in 1974, repeatedly outshining the competition to house this vital resource and distribute high-quality biomaterials for research purposes. The Repository, which facilitates cellular and molecular research studies on the mechanisms of aging and the degenerative processes associated with it, contains more than 2,000 cell lines from individuals with premature aging disorders, Alzheimer’s disease, and samples from persons of great age (90+ years).

“Diseases like Alzheimer’s and Parkinson’s ravage our seniors, weigh on their loved ones and drain patients of financial resources,” said U.S. Senator Robert Menendez. “This an investment that will assist research to treat and defeat these diseases, while lowering the costs associated with them. Coriell is helping to lead the way, once again showing how New Jersey is the innovation state.”

Scientists in more than 40 countries have utilized these vital biomaterials, resulting in the publication of more than 1,000 scientific papers describing aging-related research discoveries. These samples have been used in the identification of many disease genes, including the gene for Hutchinson Gilford Progeria Syndrome, a rare, genetic disease causing characterized by dramatic, rapid appearance of aging beginning in childhood.

With this award, Coriell is responsible for selecting, establishing, characterizing, documenting and storing new aging-related cell lines for research. Additionally, Coriell will bank induced pluripotent stem cell (iPSC) lines — cells produced by genetically reprogramming specialized cell types, like skin cells, into cells with the ability to turn into any human cell type.

“Coriell will be integrating a revolutionary technology, iPSCs, into the Repository collection to support the study of aging-related diseases. This effort will promote discovery around the causes and potential cures for devastating diseases such as Parkinson’s disease,” said Margaret Keller, Ph.D., Principal Investigator of the NIA contract. “The future holds great promise for the use of iPSCs in regenerative medicine and we are taking the first step to understand this potential.”

Since its establishment in 1953, Coriell has served the scientific community by maintaining the world’s leading cryogenic biobanking facility, distributing its more than 745,000 unique samples — encompassing cell lines, DNA, RNA, plasma, and more — to researchers in sixty-five nations. Through contracts such as the National Institutes on Aging, Coriell is able to support worldwide research initiatives with the ultimate goal of improving human health.

About Coriell
Coriell Institute for Medical Research (www.coriell.org) is an internationally known, non-profit, biomedical research institution headquartered in Camden, NJ, contiguous with the Cooper University Hospital Health Sciences Campus. Founded in 1953, Coriell is the world’s leading biobank resource for biological materials and home of the Coriell Personalized Medicine Collaborative^® (CPMC^®) research study, a forward-looking project aimed at understanding the utility of genome-informed medicine and identifying genetic variants associated with common complex disease and variation in drug response (http://cpmc.coriell.org).

About NIA
The NIA leads the federal effort supporting and conducting research on aging and the medical, social and behavioral issues of older people. For more information on research and aging, go to www.nia.nih.gov.

The NIH — the nation’s medical research agency — includes 27 institutes and centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

YOQNEAM, ISRAEL–(Marketwire – July 1, 2010) –  Given Imaging Ltd (NASDAQ: GIVN), a leader in capsule endoscopy and specialty GI diagnostics, today announced that the first in-human study analyzing remote magnetic manipulation of a PillCam video capsule was published in the June 2010 edition of Gastrointestinal Endoscopy, the journal of the American Society for Gastrointestinal Endoscopy, which validates the potential of magnetic maneuvering of the PillCam capsule endoscope. Led by Dr. Paul Swain of the Imperial College, London, United Kingdom, and sponsored by the nano-based capsule endoscopy with molecular imaging and optical biopsy (NEMO) consortium led by Given Imaging, the study aimed to assess the efficacy of remote magnetic manipulation in the esophagus and stomach by simultaneously recording the capsule’s positions and movements with the orientation and movement of the external handheld magnet.

“This study demonstrated two things: 1] we can maneuver capsule in humans and 2] that the procedure is painless. We believe that these results underscore the value of conducting additional clinical studies in humans,” said Dr. Paul Swain of the Imperial College, London, United Kingdom. “Remote manipulation may improve diagnostic accuracy and is essential for the future development of remote controlled therapy by video capsules.”

Researchers modified a PillCam^® COLON capsule to include rare earth magnetic materials and to replace the usual magnetic on/off switch with a thermal switch. An external paddle-shaped magnet was used to manipulate the capsule remotely, and Given Imaging’s RAPID^® RealTime viewer captured capsule images. Additionally, a high-definition video-gastroscope was used to observe the capsule in the esophagus and stomach, and a room video camera recorded the scene and hand movements of the endoscopist to allow coordinated time imaging of the movement of the external magnet with movements of the capsule inside the stomach and esophagus.

“As the pioneers of capsule endoscopy, Given Imaging is committed to exploring new ways to make both diagnoses and therapeutic interventions in the GI tract less invasive and more effective for patients,” said Homi Shamir, president and chief executive officer, Given Imaging. “Our relationship with the NEMO Consortium exemplifies how productive a true partnership between industry and the medical community can be at finding new ways to improve patient care.”

The exam was performed in the Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA, by Richard I. Rothstein, MD and Paul Swain of the Imperial College, London, UK in cooperation with Given Imaging. IBMT, or the Fraunhofer Institute for Biomedical Engineering, St. Ingbert, Germany, provided the external paddle-shaped magnet under the direction of Frank Volke, PhD.

About Given Imaging Ltd.
Since 2001, Given Imaging has advanced gastrointestinal visualization by developing innovative, patient-friendly tools based on its PillCam^® Platform. PillCam^® capsule endoscopy provides physicians with natural images of the small intestine via PillCam^® SB, the esophagus through PillCam^® ESO and the colon with PillCam^® COLON [PillCam COLON is not cleared for use in the USA]. The PillCam^® capsules are miniature video cameras that patients ingest. Given Imaging’s other capsule products include Agile™ patency capsule, to verify intestinal patency, and Bravo^®, the only wireless, catheter-free, 48-hour pH test commercially available for pH testing to assess gastroesophageal reflux disease (GERD). Given Imaging’s products use cutting-edge, wireless technology and advanced software to enable gastroenterologists to visualize diseases of the esophagus, small bowel and colon. All Given Imaging products allow patients to maintain normal activities. In April 2010 Given Imaging acquired Sierra Scientific Instruments, the leading provider of specialty GI diagnostic solutions and pioneer of high-resolution manometry for assessing gastrointestinal motility. Sierra Scientific is now a wholly-owned subsidiary of Given Imaging. Given Imaging’s headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel, with operating subsidiaries in the United States, Germany, France, Japan, Australia and Singapore. For more information, please visit www.givenimaging.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, projections about our business and our future revenues, expenses and profitability. Forward-looking statements may be, but are not necessarily, identified by the use of forward-looking terminology such as “may,” “anticipates,” “estimates,” “expects,” “intends,” “plans,” “believes,” and words and terms of similar substance. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual events, results, performance, circumstances or achievements of the Company to be materially different from any future events, results, performance, circumstances or achievements expressed or implied by such forward-looking statements. Factors that could cause actual events, results, performance, circumstances or achievements to differ from such forward-looking statements include, but are not limited to, the following: (1) our ability to develop and bring to market new products, (2) our ability to successfully complete any necessary or required clinical studies with our products, (3) our ability to receive regulatory clearance or approval to market our products or changes in regulatory environment, (4) our success in implementing our sales, marketing and manufacturing plans, (5) the level of adoption of our products by medical practitioners, (6) the emergence of other products that may make our products obsolete, (7) lack of an appropriate bowel preparation materials to be used with our PillCam COLON capsule, (8) protection and validity of patents and other intellectual property rights, (9) the impact of currency exchange rates, (10) the effect of competition by other companies, (11) the outcome of significant litigation, (12) our ability to obtain reimbursement for our product from government and commercial payors, (13) quarterly variations in operating results, (14) the possibility of armed conflict or civil or military unrest in Israel, (15) the impact of global economic conditions, (16) our ability to successfully integrate acquired businesses, (17) changes and reforms in applicable healthcare laws and regulations and (18) other risks and factors disclosed in our filings with the U.S. Securities and Exchange Commission, including, but not limited to, risks and factors identified under such headings as “Risk Factors,” “Cautionary Language Regarding Forward-Looking Statements” and “Operating Results and Financial Review and Prospects” in the Company’s Annual Report on Form 20-F for the year ended December 31, 2008. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except for the Company’s ongoing obligations to disclose material information under the applicable securities laws, it undertakes no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events.